Unproven Ebola Drugs Are Ethical to Use in Outbreak: WHO
This article is for subscribers only.
Developers of unproven Ebola drugs received backing from medical ethicists to deploy the therapies against the worst outbreak of the deadly disease on record.
The decision, by a panel of outside advisers to the World Health Organization, gives stricken West African nations more confidence to request drugs and may yield valuable information on whether, and how, the medicines work. Finding doses poses an immediate challenge after one drugmaker, Mapp Biopharmaceutical Inc., said yesterday it’s already exhausted its supply.